PharmacyCodes



Mononitrogen monoxide en es it fr

Mononitrogen monoxide Brand names, Mononitrogen monoxide Analogs

Mononitrogen monoxide Brand Names Mixture

  • Aldoril 15 Tab (Hydrochlorothiazide + Methyldopa)
  • Aldoril 25 Tab (Hydrochlorothiazide + Methyldopa)
  • Apo Methazide 15 (Hydrochlorothiazide + Methyldopa)
  • Apo Methazide 25 (Hydrochlorothiazide + Methyldopa)
  • Novo-Doparil 15 Tab (Hydrochlorothiazide + Methyldopa)
  • Novo-Doparil 25 Tab (Hydrochlorothiazide + Methyldopa)
  • Pms-Dopazide 15 Tab (Hydrochlorothiazide + Methyldopa)
  • Pms-Dopazide-25 Tab (Hydrochlorothiazide + Methyldopa)
  • Supres 150 Tab (Chlorothiazide + Methyldopa)
  • Supres 250 Tab (Chlorothiazide + Methyldopa)

Mononitrogen monoxide Chemical_Formula

NO

Mononitrogen monoxide RX_link

http://www.rxlist.com/cgi/generic/inomax.htm

Mononitrogen monoxide fda sheet

Mononitrogen_monoxide FDA

Mononitrogen monoxide msds (material safety sheet)

Mononitrogen_monoxide MSDS

Mononitrogen monoxide Synthesis Reference

No information avaliable

Mononitrogen monoxide Molecular Weight

30.0061 g/mol

Mononitrogen monoxide Melting Point

-163.6 oC

Mononitrogen monoxide H2O Solubility

9.49E+004 mg/L

Mononitrogen monoxide State

Liquid

Mononitrogen monoxide LogP

0.10

Mononitrogen monoxide Dosage Forms

Cream; Drops; Gas; Liquid; Lotion; Ointment; Powder; Tablet

Mononitrogen monoxide Indication

For the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure

Mononitrogen monoxide Pharmacology

Persistent pulmonary hypertension of the newborn (PPHN) occurs as a primary developmental defect or as a condition secondary to other diseases such as meconium aspiration syndrome (MAS), pneumonia, sepsis, hyaline membrane disease, congenital diaphragmatic hernia (CDH), and pulmonary hypoplasia. In these states, pulmonary vascular resistance (PVR) is high, which results in hypoxemia secondary to right-to-left shunting of blood through the patent ductus arteriosus and foramen ovale. In neonates with PPHN, Nitric oxide improves oxygenation (as indicated by significant increases in PaO2). Nitric oxide appears to increase the partial pressure of arterial oxygen (PaO2) by dilating pulmonary vessels in better entilated areas of the lung, redistributing pulmonary blood flow away from lung regions with low ventilation/perfusion (V/Q) ratios toward regions with normal ratios.

Mononitrogen monoxide Absorption

Nitric oxide is absorbed systemically after inhalation.

Mononitrogen monoxide side effects and Toxicity

No information avaliable

Mononitrogen monoxide Patient Information

No information avaliable

Mononitrogen monoxide Organisms Affected

Humans and other mammals